Del Rio J, Madroñal J
Eur J Pharmacol. 1976 Oct;39(2):267-74. doi: 10.1016/0014-2999(76)90135-7.
Triperidol was found to be a more potent 3H-dopamine uptake inhibitor than chlorpromazine in homogenates from rat striatum. Inhibition kinetics were competitive for triperidol and non-competitive for chlorpromazine. When drugs were given in vivo, d-amphetamine (10 mg/kg) blocked the 3H-dopamine uptake by about 50% whereas the neuroleptics did not modify the process even at highly sedating doses. Combined treatments with d-amphetamine and neuroleptics showed that only triperidol potentiated the blocking effect of d-amphetamine on 3-H-dopamine uptake. However, such a potentiation was not observed when triperidol and d-amphetamine were simultaneously added in vitro. The results tend to suggest that the postulated actions of neuroleptics on presynaptic sites in the striatum may be more important with the butyrophenone, triperidol than with the phenothiazine, chlorpromazine.
在大鼠纹状体匀浆中,发现三氟哌多是比氯丙嗪更强效的3H-多巴胺摄取抑制剂。三氟哌多的抑制动力学为竞争性,氯丙嗪为非竞争性。当体内给药时,d-苯丙胺(10mg/kg)可使3H-多巴胺摄取阻断约50%,而即使在高镇静剂量下,抗精神病药物也不会改变这一过程。d-苯丙胺与抗精神病药物联合治疗表明,只有三氟哌多能增强d-苯丙胺对3-H-多巴胺摄取的阻断作用。然而,当三氟哌多和d-苯丙胺在体外同时添加时,未观察到这种增强作用。结果倾向于表明,与吩噻嗪类药物氯丙嗪相比,丁酰苯类药物三氟哌多对纹状体突触前位点的假定作用可能更为重要。